Financial Ratios Metropolis Healthcare Limited
Equities
METROPOLIS
INE112L01020
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,906.80 INR | +1.69% |
|
-6.06% | -1.15% |
| Jan. 04 | Metropolis Health standalone revenue growth at 15% YoY | RE |
| Nov. 06 | Metropolis Healthcare Limited, Q2 2026 Earnings Call, Nov 06, 2025 |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 17.25 | 13.89 | 8.4 | 7.98 | 7.15 | |||||
Return on Total Capital | 21.45 | 16.87 | 10.09 | 9.55 | 8.63 | |||||
Return On Equity % | 29.73 | 26.9 | 15.26 | 12.29 | 11.96 | |||||
Return on Common Equity | 29.77 | 26.89 | 15.25 | 12.26 | 11.95 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 72.92 | 75.77 | 76.13 | 77.65 | 77.24 | |||||
SG&A Margin | 27.52 | 29.68 | 32.48 | 34.26 | 36.04 | |||||
EBITDA Margin % | 26.38 | 24.97 | 20.52 | 18.02 | 16.23 | |||||
EBITA Margin % | 24.53 | 23.27 | 18.26 | 16.65 | 15.13 | |||||
EBIT Margin % | 24.28 | 22.93 | 17.74 | 16.16 | 14.7 | |||||
Income From Continuing Operations Margin % | 18.37 | 17.48 | 12.49 | 10.64 | 10.93 | |||||
Net Income Margin % | 18.35 | 17.44 | 12.44 | 10.58 | 10.89 | |||||
Net Avail. For Common Margin % | 18.35 | 17.44 | 12.44 | 10.58 | 10.89 | |||||
Normalized Net Income Margin | 15.23 | 14.07 | 10.13 | 8.93 | 8.48 | |||||
Levered Free Cash Flow Margin | 19.75 | 14.03 | 12.17 | 14.55 | 11.72 | |||||
Unlevered Free Cash Flow Margin | 20.24 | 15.03 | 13.63 | 15.72 | 12.59 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.14 | 0.97 | 0.76 | 0.79 | 0.78 | |||||
Fixed Assets Turnover | 5 | 5.26 | 4.11 | 3.74 | 3.82 | |||||
Receivables Turnover (Average Receivables) | 7.94 | 9.5 | 8.92 | 9.73 | 9.71 | |||||
Inventory Turnover (Average Inventory) | 8.32 | 6.49 | 5.73 | 6.48 | 7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.98 | 1.3 | 1.14 | 1.28 | 1.18 | |||||
Quick Ratio | 2.67 | 1.07 | 0.83 | 0.99 | 0.91 | |||||
Operating Cash Flow to Current Liabilities | 1.22 | 0.84 | 0.93 | 1.07 | 0.89 | |||||
Days Sales Outstanding (Average Receivables) | 45.94 | 38.4 | 40.91 | 37.6 | 37.6 | |||||
Days Outstanding Inventory (Average Inventory) | 43.87 | 56.2 | 63.73 | 56.47 | 52.13 | |||||
Average Days Payable Outstanding | 124.65 | 126.59 | 134.58 | 134.16 | 131.74 | |||||
Cash Conversion Cycle (Average Days) | -34.85 | -31.99 | -29.94 | -40.08 | -42.02 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 15.86 | 42.62 | 26.89 | 17.93 | 15.29 | |||||
Total Debt / Total Capital | 13.69 | 29.88 | 21.19 | 15.2 | 13.27 | |||||
LT Debt/Equity | 11.15 | 27.17 | 15.56 | 10.83 | 8.4 | |||||
Long-Term Debt / Total Capital | 9.62 | 19.05 | 12.26 | 9.18 | 7.28 | |||||
Total Liabilities / Total Assets | 29.5 | 41.96 | 34.02 | 29.31 | 28.53 | |||||
EBIT / Interest Expense | 31.14 | 14.27 | 7.6 | 8.66 | 10.53 | |||||
EBITDA / Interest Expense | 36.42 | 17.11 | 10.61 | 12.41 | 15.34 | |||||
(EBITDA - Capex) / Interest Expense | 32.79 | 15.56 | 8.65 | 9.58 | 13 | |||||
Total Debt / EBITDA | 0.4 | 1.12 | 0.94 | 0.7 | 0.72 | |||||
Net Debt / EBITDA | -1.09 | 0.59 | 0.61 | 0.29 | 0.3 | |||||
Total Debt / (EBITDA - Capex) | 0.44 | 1.23 | 1.15 | 0.91 | 0.85 | |||||
Net Debt / (EBITDA - Capex) | -1.21 | 0.64 | 0.74 | 0.38 | 0.36 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 16.53 | 23.08 | -6.52 | 5.18 | 10.23 | |||||
Gross Profit, 1 Yr. Growth % | 13.87 | 27.88 | -6.08 | 7.28 | 9.64 | |||||
EBITDA, 1 Yr. Growth % | 22.55 | 16.49 | -23.2 | -7.63 | -0.7 | |||||
EBITA, 1 Yr. Growth % | 24.73 | 16.74 | -26.66 | -4.09 | 0.17 | |||||
EBIT, 1 Yr. Growth % | 24.82 | 16.22 | -27.68 | -4.22 | 0.27 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 43.74 | 17.09 | -33.21 | -10.42 | 13.28 | |||||
Net Income, 1 Yr. Growth % | 43.8 | 16.98 | -33.29 | -10.54 | 13.42 | |||||
Normalized Net Income, 1 Yr. Growth % | 26.27 | 13.68 | -32.67 | -7.32 | 4.76 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 41.74 | 16.4 | -33.25 | -10.57 | 13.19 | |||||
Accounts Receivable, 1 Yr. Growth % | -4.11 | 10.17 | -10.04 | 3.6 | 17.16 | |||||
Inventory, 1 Yr. Growth % | 66.18 | 26.04 | -12.75 | -13.23 | 23.64 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 20.69 | 13.95 | 24.89 | 8.17 | 7.29 | |||||
Total Assets, 1 Yr. Growth % | 33.52 | 52.36 | -1.87 | 3.56 | 20.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 43.65 | -87.93 | 126.02 | 60.76 | -4.16 | |||||
Common Equity, 1 Yr. Growth % | 34.98 | 25.42 | 11.51 | 10.92 | 21.42 | |||||
Cash From Operations, 1 Yr. Growth % | 15.83 | 1.7 | -2.44 | 6.87 | -0.5 | |||||
Capital Expenditures, 1 Yr. Growth % | -21.91 | 8.45 | 71.65 | 21.14 | -31.92 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 8.81 | -12.6 | -18.92 | 37.29 | -15.22 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 8.38 | -8.6 | -15.27 | 31.14 | -15.39 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | -50 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 14.5 | 19.76 | 7.26 | -0.84 | 7.67 | |||||
Gross Profit, 2 Yr. CAGR % | 12.37 | 20.67 | 9.6 | 0.38 | 8.46 | |||||
EBITDA, 2 Yr. CAGR % | 14.29 | 19.48 | -5.41 | -15.77 | -4.23 | |||||
EBITA, 2 Yr. CAGR % | 15.08 | 20.67 | -7.47 | -16.13 | -1.98 | |||||
EBIT, 2 Yr. CAGR % | 15.05 | 20.44 | -8.32 | -16.77 | -2 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 21.79 | 29.74 | -11.56 | -22.65 | 0.74 | |||||
Net Income, 2 Yr. CAGR % | 23.45 | 29.7 | -11.66 | -22.75 | 0.73 | |||||
Normalized Net Income, 2 Yr. CAGR % | 16.09 | 19.81 | -12.51 | -21.01 | -1.47 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 22.07 | 28.45 | -11.85 | -22.74 | 0.61 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5.2 | 2.78 | -0.44 | -3.46 | 10.17 | |||||
Inventory, 2 Yr. CAGR % | 24.64 | 44.72 | 4.87 | -12.99 | 3.58 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 36.78 | 17.27 | 19.3 | 16.23 | 7.73 | |||||
Total Assets, 2 Yr. CAGR % | 34.81 | 42.63 | 22.27 | 0.81 | 11.52 | |||||
Tangible Book Value, 2 Yr. CAGR % | 35.55 | -58.36 | -47.77 | 90.62 | 24.13 | |||||
Common Equity, 2 Yr. CAGR % | 29.93 | 30.11 | 18.26 | 11.22 | 16.05 | |||||
Cash From Operations, 2 Yr. CAGR % | 66.2 | 8.54 | -0.39 | 2.11 | 3.12 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.23 | -7.97 | 36.44 | 44.2 | -9.18 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 78.86 | -2.48 | -15.82 | 0.99 | 10.39 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 80.56 | -0.47 | -11.99 | 1.39 | 7.6 | |||||
Dividend Per Share, 2 Yr. CAGR % | -22.33 | 0 | 0 | -29.29 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.53 | 17.29 | 10.27 | 6.56 | 2.72 | |||||
Gross Profit, 3 Yr. CAGR % | 14.1 | 17.32 | 11 | 8.82 | 3.38 | |||||
EBITDA, 3 Yr. CAGR % | 13.32 | 15.02 | 3.11 | -6.16 | -11.02 | |||||
EBITA, 3 Yr. CAGR % | 14.26 | 15.63 | 2.21 | -6.36 | -11.02 | |||||
EBIT, 3 Yr. CAGR % | 14.29 | 15.44 | 1.61 | -6.97 | -11.44 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 17.91 | 20.2 | 3.98 | -11.18 | -12.16 | |||||
Net Income, 3 Yr. CAGR % | 20.66 | 21.25 | 3.92 | -11.29 | -12.2 | |||||
Normalized Net Income, 3 Yr. CAGR % | 16.72 | 15.28 | -1.13 | -10.82 | -13.21 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 19.66 | 20.15 | 3.27 | -11.43 | -12.25 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.89 | -0.33 | -1.68 | 0.89 | 2.98 | |||||
Inventory, 3 Yr. CAGR % | 24.16 | 25.1 | 22.26 | -1.55 | -2.18 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 24.8 | 28.7 | 19.76 | 15.47 | 13.17 | |||||
Total Assets, 3 Yr. CAGR % | 23.72 | 40.42 | 25.91 | 15.69 | 6.86 | |||||
Tangible Book Value, 3 Yr. CAGR % | 22.1 | -39.47 | -26.82 | -24.02 | 51.58 | |||||
Common Equity, 3 Yr. CAGR % | 19.43 | 28.41 | 23.59 | 15.76 | 14.52 | |||||
Cash From Operations, 3 Yr. CAGR % | 33.81 | 41.1 | 4.75 | 1.97 | 1.23 | |||||
Capital Expenditures, 3 Yr. CAGR % | 21.76 | 16.17 | 13.28 | 31.14 | 12.29 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 157.7 | 40.88 | -8.3 | -3.76 | -3.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 154.36 | 43.9 | -5.67 | -2.05 | -3.18 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -15.5 | 0 | -20.63 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.98 | 17.66 | 12.15 | 9.67 | 9.22 | |||||
Gross Profit, 5 Yr. CAGR % | 16.12 | 18.22 | 12.28 | 10.23 | 9.98 | |||||
EBITDA, 5 Yr. CAGR % | 15.63 | 14.99 | 5.42 | 1.54 | 0.11 | |||||
EBITA, 5 Yr. CAGR % | 17.11 | 16 | 5.01 | 1.69 | 0.51 | |||||
EBIT, 5 Yr. CAGR % | 16.87 | 15.71 | 4.64 | 1.28 | 0.15 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 17.47 | 14.89 | 5.1 | 0.77 | 2.67 | |||||
Net Income, 5 Yr. CAGR % | 18.98 | 16.07 | 6.51 | 1.25 | 2.63 | |||||
Normalized Net Income, 5 Yr. CAGR % | 17.57 | 14.96 | 4.01 | -0.9 | -1.27 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 18.78 | 15.41 | 5.89 | 0.7 | 2.2 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.87 | 11.03 | 3.9 | -1.59 | 2.9 | |||||
Inventory, 5 Yr. CAGR % | 21.1 | 29.32 | 16.05 | 8.19 | 14.41 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 15.51 | 18.57 | 22.57 | 23.56 | 14.79 | |||||
Total Assets, 5 Yr. CAGR % | 20.47 | 24.33 | 23.14 | 22.99 | 19.94 | |||||
Tangible Book Value, 5 Yr. CAGR % | 19.11 | -20.85 | -13.07 | -4.23 | -9.6 | |||||
Common Equity, 5 Yr. CAGR % | 20.45 | 22.35 | 18.96 | 21.23 | 20.52 | |||||
Cash From Operations, 5 Yr. CAGR % | 22.19 | 20.01 | 18.91 | 23.98 | 4.09 | |||||
Capital Expenditures, 5 Yr. CAGR % | 11.47 | 13.11 | 27.43 | 26.66 | 3.7 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.79 | 4.91 | 64.72 | 23.32 | -2.95 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.23 | 6.33 | 66.37 | 25.1 | -2.1 | |||||
Dividend Per Share, 5 Yr. CAGR % | -12.35 | -4.52 | - | -21.31 | - |
Select your edition
All financial news and data tailored to specific country editions
















